Uganda Pharmaceutical Market 2022-2030

    Multi User License - $2,999

    In Stock

    Coming Soon

     

    UGANDA PHARMACEUTICAL MARKET

     

    INTRODUCTION

    Uganda’s pharmaceutical industry will continue to be small, underfunded, and dominated by generics.

    Infpgraphics: Uganda Pharmaceutical Market , Uganda Pharmaceutical Market Size, Uganda Pharmaceutical Market Trends, Uganda Pharmaceutical Market Forecast, Uganda Pharmaceutical Market Risks, Uganda Pharmaceutical Market Report, Uganda Pharmaceutical Market Share

    Opportunities for innovative drugmakers looking to launch patented medicines in Uganda will be limited by a combination of low per capita spending and a youth-dominated and highly ruralized population.

     

    With potential licensing agreements with local players who are able to advance their manufacturing capabilities over the coming years, opportunities for foreign firms will largely be indirect. 

     

    Generic medicines make up the majority of Uganda’s pharmaceutical market due to the country’s low purchasing power.Patented medicines only make up a small portion of the market because most people can’t afford to buy higher-priced patented medicines because of the low cost of drugs per capita.

     

    Using tiered pricing, multinational pharmaceutical companies might try to get more people to use patented products.

     

    In Uganda, self-medication is common, making the over-the-counter (OTC) drug market appealing.        Due to a lack of healthcare infrastructure or financial constraints, many Ugandans do not have access to medical facilities.

     

    Roadside kiosks that sell malaria medications and antibiotics blur the line between prescription and over-the-counter medications, as evidenced by the rapid expansion of pharmacies in both urban and rural areas.

     

    The local production of medicines faces obstacles, including inadequate infrastructure. The country’s membership in COMESA should make it more appealing to businesses looking to manufacture goods there. 

    UGANDA PHARMACEUTICAL MARKET SIZE AND FORECAST

    The Uganda Pharmaceutical Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.

     

    NEW PRODUCT LAUNCH

    The Dei Biopharma manufacturing facility in Matugga, close to Kampala, was inaugurated.  The ceremony took place in Luwero, Uganda.

     

    The pharmaceutical plant will produce affordable, high-quality medicines for a variety of medical conditions, including malaria and cancer treatment, which will benefit millions of African families.

     

    Investments like these will help Uganda become a modern economy driven by growth and development. Dei BioPharma Uganda Ltd. is a Uganda-based pharmaceutical and food (nutraceuticals and pharmaceutical) research company that produces cosmetics, food supplements, and medicines. 

     

    In addition, the facility is the only pharmaceutical company in Africa producing therapeutic Covid-19 medications and preparing to produce one billion doses of mRNA vaccines in accordance with WHO standards.

     

    The Equity Group has provided partner funding for the facility’s development. 

     

    Dei BioPharma has secured more than 3,000 formulations, giving it a wide range of potential drugs for production, including vaccines, drugs to treat cancer, therapeutic proteins, peptides, and cell therapy, among other things.

     

    COMPANY PROFILE

    • Allied Pharma Ltd
    • Ankole Pharmaceuticals Ltd (Golden Seal Pharmaceutical)
    • Bremut Uganda Ltd
    • C & A Pharmacy
    • Critical Care Solutions
    • Eden Uganda Ltd
    • Elite Pharmaceuticals Ltd

     

    THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

    1. What is the average cost per Uganda Pharmaceutical Market right now and how will it change in the next 5-6 years?
    2. Average cost to set up a Pharmaceutical Market in Uganda?
    3. How many Uganda Pharmaceutical Market are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    4. What is happening in the overall public, globally?
    5. Cost breakup of a Uganda Pharmaceutical Market and key vendor selection criteria
    6. Where is the Uganda Pharmaceutical Market manufactured? What is the average margin per equipment?
    7. Market share of Uganda Pharmaceutical Market  manufacturers and their upcoming products
    8. The most important planned Uganda Pharmaceutical Market in next 2 years
    9. Details on network of major Uganda Pharmaceutical Market and pricing plans
    10. Cost advantage for OEMs who manufacture Uganda Pharmaceutical Market in-house
    11. 5 key predictions for next 5 years in Uganda Pharmaceutical Market
    12. Average B-2-B Uganda Pharmaceutical Market price in all segments
    13. Latest trends in Uganda Pharmaceutical Market, by every market segment
    14. The market size (both volume and value) of Uganda Pharmaceutical Market in 2022-2030 and every year in between?
    15. Global production breakup of Uganda Pharmaceutical Market, by suppliers and their OEM relationship

     

    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2022-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2022-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2022-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2022-2030
    21 Product installation rate by OEM, 2022
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2022
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
    0
      0
      Your Cart
      Your cart is emptyReturn to Shop